TTrialPathMatch Me to Trials
← Back to trials
RecruitingSquamous Cell CarcinomaNonmelanoma Skin CancerCutaneous Squamous Cell Carcinoma

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to research if a type of biopsy known as sentinel lymph node biopsy (SLNB) can help in determining the rate of tumor deposits that are hard to detect and identify in node-negative cutaneous squamous cell carcinoma of the head or neck.

Sponsor: Indiana University

You may qualify if…

  • ✓ Patients ≥ 18 years old at the time of informed consent
  • ✓ Ability to provide written informed consent and HIPAA authorization
  • ✓ Primary or recurrent invasive cutaneous squamous cell carcinoma of the head or neck, clinically staged T2-T4 based on AJCC staging
  • ✓ Clinically and radiographically regional node-negative (no evidence of regional lymph node metastasis or distant metastasis)
  • ✓ Able to undergo general anesthesia for sentinel lymph node biopsy
  • ✓ Able to undergo CT scan with contrast or MRI with contrast
  • ✓ Undergo surgical resection (Moh's or micrographic resection or standard excision with sentinel lymph node biopsy) within 8 weeks of imaging

You may not qualify if…

  • ✕ Clinical evidence of satellite lesions, in-transit, regional nodal or distant metastases
  • ✕ Known biopsy proven synchronous primary cutaneous squamous cell carcinoma
  • ✕ Pregnant patients
  • ✕ Patients unable to undergo general anesthesia
  • ✕ Patient unable to receive contrasted imaging studies
  • ✕ Patient unable to receive and/or allergic to 99m-Technetium sulfur colloid

Where it's recruiting

Indiana

Indianapolis

Source: ClinicalTrials.gov · NCT05108090 · last updated 2025-06-11

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of th · TrialPath